Cargando…

Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus

Detalles Bibliográficos
Autores principales: August, Allison, Attarwala, Husain Z., Himansu, Sunny, Kalidindi, Shiva, Lu, Sophia, Pajon, Rolando, Han, Shu, Lecerf, Jean-Michel, Tomassini, Joanne E., Hard, Marjie, Ptaszek, Leon M., Crowe, James E., Zaks, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117134/
https://www.ncbi.nlm.nih.gov/pubmed/35449420
http://dx.doi.org/10.1038/s41591-022-01817-z
_version_ 1784710264912871424
author August, Allison
Attarwala, Husain Z.
Himansu, Sunny
Kalidindi, Shiva
Lu, Sophia
Pajon, Rolando
Han, Shu
Lecerf, Jean-Michel
Tomassini, Joanne E.
Hard, Marjie
Ptaszek, Leon M.
Crowe, James E.
Zaks, Tal
author_facet August, Allison
Attarwala, Husain Z.
Himansu, Sunny
Kalidindi, Shiva
Lu, Sophia
Pajon, Rolando
Han, Shu
Lecerf, Jean-Michel
Tomassini, Joanne E.
Hard, Marjie
Ptaszek, Leon M.
Crowe, James E.
Zaks, Tal
author_sort August, Allison
collection PubMed
description
format Online
Article
Text
id pubmed-9117134
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-91171342022-05-20 Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus August, Allison Attarwala, Husain Z. Himansu, Sunny Kalidindi, Shiva Lu, Sophia Pajon, Rolando Han, Shu Lecerf, Jean-Michel Tomassini, Joanne E. Hard, Marjie Ptaszek, Leon M. Crowe, James E. Zaks, Tal Nat Med Author Correction Nature Publishing Group US 2022-04-21 2022 /pmc/articles/PMC9117134/ /pubmed/35449420 http://dx.doi.org/10.1038/s41591-022-01817-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Author Correction
August, Allison
Attarwala, Husain Z.
Himansu, Sunny
Kalidindi, Shiva
Lu, Sophia
Pajon, Rolando
Han, Shu
Lecerf, Jean-Michel
Tomassini, Joanne E.
Hard, Marjie
Ptaszek, Leon M.
Crowe, James E.
Zaks, Tal
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
title Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
title_full Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
title_fullStr Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
title_full_unstemmed Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
title_short Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
title_sort author correction: a phase 1 trial of lipid-encapsulated mrna encoding a monoclonal antibody with neutralizing activity against chikungunya virus
topic Author Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117134/
https://www.ncbi.nlm.nih.gov/pubmed/35449420
http://dx.doi.org/10.1038/s41591-022-01817-z
work_keys_str_mv AT augustallison authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT attarwalahusainz authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT himansusunny authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT kalidindishiva authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT lusophia authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT pajonrolando authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT hanshu authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT lecerfjeanmichel authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT tomassinijoannee authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT hardmarjie authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT ptaszekleonm authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT crowejamese authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus
AT zakstal authorcorrectionaphase1trialoflipidencapsulatedmrnaencodingamonoclonalantibodywithneutralizingactivityagainstchikungunyavirus